Patent · US Active

Gene signatures for cancer diagnosis and prognosis

US9605319B2 · kind B2 · utility

1Cited by

16References

8Claims

0Family size

Assignee

Myriad Genetics, Inc. · US

Inventors

Steven Stone · Salt Lake City, US
Alexander Gutin · Salt Lake City, US
Susanne Wagner · Mittenwalde, DE
Julia Reid · Salt Lake City, US

Key dates

Filing date	Aug 30, 2011
Grant date	Mar 28, 2017
Priority date	—
Expiry date	Jul 25, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG16B25/00
WIPO fieldComputer technology
WIPO sectorElectrical engineering

Abstract

Biomarkers and methods using the biomarkers for molecular detection and classification of disease and, particularly, molecular markers for cancer diagnosis and prognosis and methods of use thereof are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.